InvestSMART

pSivida Limited (ASX: PSD) - Announcements

DELISTED - Current share price for PSD : $0.093

ASX company news and announcements for pSivida Limited (PSD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All pSivida Limited (PSD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than pSivida Limited (PSD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for pSivida Limited (PSD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Commitments Test Entity - Second Quarter Report 31 Jan 2006 3:53PM $0.620 $0.093 fallen by 85%
- New Pharma Drug Delivery Evaluation Agreements-US Subs. 5 Jan 2006 9:48AM $0.700 $0.093 fallen by 86.71%
- pSivida Completes Acquisition of Control Delivery Systems 3 Jan 2006 12:03PM $0.715 $0.093 fallen by 86.99%
- Trading Halt 3 Jan 2006 9:51AM $0.715 $0.093 fallen by 86.99%
- Information Statement on acquisition of CDS 23 Dec 2005 1:44PM $0.745 $0.093 fallen by 87.52%
- AION Diagnostics Develop Product Pipeline/Preclinical Trials 6 Dec 2005 9:49AM $0.605 $0.093 fallen by 84.63%
- Launces pSiNutria in the Food Industry 1 Dec 2005 9:57AM $0.630 $0.093 fallen by 85.24%
- Response to ASX Share Price Query 28 Nov 2005 7:40PM $0.600 $0.093 fallen by 84.50%
- Quarterly Cashflow Commentary & Highlights - September 2005 31 Oct 2005 6:24PM $0.720 $0.093 fallen by 87.08%
- Commitments Test Entity - First Quarter Report 31 Oct 2005 6:21PM $0.730 $0.093 fallen by 87.26%
- Commencement of Phase IIb Clinical Trials for BrachySil 31 Oct 2005 10:17AM $0.795 $0.093 fallen by 88.30%
- Beijing Med-Pharm Licence 27 Oct 2005 9:42AM $0.755 $0.093 fallen by 87.68%
- Open Briefing pSivida MD on CDS Acquisition 13 Oct 2005 9:53AM $0.800 $0.093 fallen by 88.38%
- Retisert approved for US Medicare rebate 7 Oct 2005 10:26AM $0.775 $0.093 fallen by 88%
- Secures additional US$15m funding 6 Oct 2005 12:27PM $0.755 $0.093 fallen by 87.68%
- Trading Halt 6 Oct 2005 9:58AM $0.755 $0.093 fallen by 87.68%
- CDS Launches Phase III Trial for Retinal Condition 4 Oct 2005 2:19PM $0.835 $0.093 fallen by 88.86%
- To acquire Control Delivery Systems 4 Oct 2005 9:57AM $0.835 $0.093 fallen by 88.86%
- Preliminary Final Report 13 Sep 2005 7:42PM $0.810 $0.093 fallen by 88.52%
- Collaboration with Cirrus Pharmaceuticals 6 Sep 2005 10:02AM $0.820 $0.093 fallen by 88.66%
- Closes ADR PIPE after raising US$4.2m 24 Aug 2005 9:59AM $0.840 $0.093 fallen by 88.93%
- 5th US Patent Granted 16 Aug 2005 9:38AM $0.925 $0.093 fallen by 89.95%
- In negotiations regarding potential acquisition 15 Aug 2005 10:14AM $0.945 $0.093 fallen by 90.16%
- Reinstatement to Official Quotation 15 Aug 2005 10:14AM $0.945 $0.093 fallen by 90.16%
- Suspension from Official Quotation 8 Aug 2005 9:37AM n/a $0.093 n/a

76 - 100 of 141 results

Page 4 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.